7T 2D Qflow is capable of measuring blood flow velocity in the superficial perforating arteries. These arteries run though the semi oval center of the white matter in the brain and have diameters smaller than 200 µm. Due to the small diameters, partial volume effects of perforators with surrounding tissue cause velocity underestimation. With simulations and experiments we show that tilt optimized nonsaturated excitation (TONE) significantly increases SNR and decreases velocity underestimation in superficial perforating arteries.
Eight healthy volunteers were scanned on a 7T MRI system (Philips Healthcare) with a 32 channel receive coil and a volume T/R coil for transmission (Nova Medical). The previously published 2D Qflow acquisition was modified by applying a tilt optimized nonsaturated excitation (TONE) pulse.2 To test the effect of applying a TONE pulse on velocity underestimation, a slice was acquired without TONE (flip angle (fa) = 60) and with TONE (fa = 50-70). See Table 1 for further acquisition parameters. The 2D Qflow acquisition was alternated with a fast T1 weighted 3D TFE (T1w) acquisition for white matter segmentation. Noise was estimated from the variance of static tissue over the cardiac cycle, and perforators were detected based on significant (i.e. above the noise threshold) mean velocity (Vmean). Detected perforators were matched between acquisitions, and the signal to noise ratio of the velocity (SNRv) and Vmean were tested for differences with a paired two sample t-test.
The effect of TONE on SNR, detectability and Vmean was also simulated. The excitation profile was computed for the default pulse and the TONE pulse using the Bloch equations.4 Flip angles and voxel dimensions were set as during the acquisitions (Table 1). Signal was then calculated for tissue and blood with relaxation times T1/T2 is 2100/32 ms for blood and 1200/27 ms for white matter.5–7 Monte Carlo simulation was used to incorporate the effect of noise. The SNR of static tissue was based on the SNR observed in the acquired images and set to 7. The same criterium for significant flow as described above was used to determine vessel detectability.
Figure 1 compares the measured quantities for no TONE versus TONE acquisitions. The number of detected vessels (Ndetected) increased significantly from (mean [range]) 47 [18-80] to 59 [21-102] (P<0.01). SNRv increased significantly from (mean±stderr) 3.56±0.20 to 3.82±0.21 (P<0.01). Vmean increased significantly from (mean±stderr) 0.53±0.04 to 0.67±0.04 cm/s (P<0.001).
The simulations of the effect of the TONE pulse showed a decreased underestimation of the velocity due to the partial volume effect, as shown in figure 2. The area of combinations of vessel diameters and blood flow velocities that are detectable by this technique increased from 73% to 90% of tested velocity – diameter combinations in figure 2. The minimal detectable diameter decreased from 83 µm to 53 µm.
1. Pantoni, L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 9, 689–701 (2010).
2. Bouvy, W. H. et al. Assessment of blood flow velocity and pulsatility in cerebral perforating arteries with 7-T quantitative flow MRI. NMR Biomed. (2015).
3. Eissa, A. & Wilman, A. H. Ramped RF Excitation in 3DTOF MR Angiography at High Magnetic Field. Blood 11, 2004–2004 (2004).
4. Matsuda, T. et al. An asymmetric slice profile: spatial alteration of flow signal response in 3D time-of-flight NMR angiography. Magn. Reson. Med. 29, 783–789 (1993).
5. Peters, A. M. et al. T2* measurements in human brain at 1.5, 3 and 7 T. Magn. Reson. Imaging 25, 748–753 (2007).
6. Zhang, X. et al. In vivo blood T1 measurements at 1.5 T, 3 T, and 7 T. Magn. Reson. Med. 70, 1082–1086 (2013).
7. Rooney, W. D. et al. Magnetic field and tissue dependencies of human brain longitudinal 1H2O relaxation in vivo. Magn. Reson. Med. 57, 308–318 (2007).